Item Type | Name |
Academic Article
|
Modem transmission of glucose values reduces the costs and need for clinic visits.
|
Academic Article
|
Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
|
Academic Article
|
The role of continuous glucose sensors in diabetes care.
|
Academic Article
|
Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control.
|
Academic Article
|
Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes.
|
Academic Article
|
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
|
Academic Article
|
Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population.
|
Academic Article
|
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
|
Academic Article
|
Use of continuous glucose monitoring to improve diabetes mellitus management.
|
Academic Article
|
Use of continuous glucose monitoring in patients with type 1 diabetes.
|
Academic Article
|
Role of emerging new technologies.
|
Academic Article
|
Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes.
|
Academic Article
|
Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems.
|
Academic Article
|
The future of continuous glucose monitoring.
|
Academic Article
|
Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
|
Academic Article
|
Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study.
|
Academic Article
|
HbA1c and blood glucose for the diagnosis of diabetes.
|
Academic Article
|
International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.
|
Academic Article
|
Emerging diabetes therapies and technologies.
|
Academic Article
|
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
|
Academic Article
|
Self-monitoring of blood glucose--an overview.
|
Academic Article
|
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile.
|
Academic Article
|
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).
|
Academic Article
|
Standardization of self-monitoring of blood glucose and continuous glucose monitoring reporting.
|
Academic Article
|
Continuous glucose monitoring in type 1 diabetes.
|
Academic Article
|
Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine.
|
Academic Article
|
Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor.
|
Academic Article
|
Use of the GlucoWatch biographer in children with type 1 diabetes.
|
Academic Article
|
Treatment of adolescents with type 1 diabetes mellitus.
|
Academic Article
|
The clinical performance and ease of use of a blood glucose meter that uses a 10-test disk.
|
Academic Article
|
Health impact from frequent and continuous glucose monitoring.
|
Academic Article
|
Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
|
Academic Article
|
Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
|
Academic Article
|
Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.
|
Academic Article
|
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes.
|
Academic Article
|
Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
|
Academic Article
|
Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes.
|
Academic Article
|
Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
|
Academic Article
|
Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes.
|
Academic Article
|
Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.
|
Academic Article
|
Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.
|
Academic Article
|
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.
|
Academic Article
|
Time lag characterization of two continuous glucose monitoring systems.
|
Academic Article
|
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.
|
Academic Article
|
Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
|
Academic Article
|
Intensive insulin therapy in patients with type 1 diabetes mellitus.
|
Concept
|
Blood Pressure
|
Concept
|
Blood Glucose
|
Concept
|
Blood Chemical Analysis
|
Concept
|
Blood Glucose Self-Monitoring
|
Academic Article
|
Threshold-based insulin-pump interruption for reduction of hypoglycemia.
|
Academic Article
|
Use of non-insulin therapies for type 1 diabetes.
|
Academic Article
|
Diabetes duration and the efficacy and safety of insulin glargine versus comparator treatment in patients with type 2 diabetes mellitus.
|
Academic Article
|
Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
|
Academic Article
|
Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.
|
Academic Article
|
Self-monitoring of blood glucose--an overview.
|
Academic Article
|
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor.
|
Academic Article
|
Closed-loop system in the management of diabetes: past, present, and future.
|
Academic Article
|
Self-monitoring of blood glucose.
|
Academic Article
|
Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS study.
|
Academic Article
|
Self-monitoring of blood glucose.
|
Academic Article
|
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
|
Academic Article
|
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.
|
Academic Article
|
Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research.
|
Academic Article
|
Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.
|
Academic Article
|
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline Characteristics.
|
Academic Article
|
The Future of Glucose Monitoring.
|
Academic Article
|
Self-Monitoring of Blood Glucose.
|
Academic Article
|
Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
|
Academic Article
|
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes.
|
Academic Article
|
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
|
Academic Article
|
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
|
Academic Article
|
Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China.
|
Academic Article
|
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
|
Academic Article
|
Self-Monitoring of Blood Glucose.
|
Academic Article
|
Evaluation of a Predictive Low-Glucose Management System In-Clinic.
|
Academic Article
|
Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.
|
Academic Article
|
Flash Glucose Monitoring: The Future Is Here.
|
Academic Article
|
The Future of Continuous Glucose Monitoring.
|
Academic Article
|
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor.
|
Academic Article
|
Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine-SORELLA 1 Study.
|
Academic Article
|
Continuous glucose monitoring in pregnant women with type 1 diabetes.
|
Academic Article
|
Trypanosoma evansi induces detrimental immuno-catabolic alterations and condition like type-2 diabetes in buffaloes.
|
Academic Article
|
The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed? 670G Hybrid Closed-Loop System.
|
Academic Article
|
International Consensus on Use of Continuous Glucose Monitoring.
|
Academic Article
|
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes.
|
Academic Article
|
Self-Monitoring of Blood Glucose.
|
Academic Article
|
Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
|
Academic Article
|
Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127.
|
Academic Article
|
SGLT inhibition: a possible adjunctive treatment for type 1 diabetes.
|
Academic Article
|
Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
|
Academic Article
|
A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices.
|
Academic Article
|
Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.
|
Academic Article
|
Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes.
|
Academic Article
|
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
|
Academic Article
|
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
|
Academic Article
|
Technological advances shaping diabetes care.
|
Academic Article
|
Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
|
Academic Article
|
Self-Monitoring of Blood Glucose.
|
Academic Article
|
New Medications for the Treatment of Diabetes.
|
Academic Article
|
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
|
Academic Article
|
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes.
|
Academic Article
|
Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials.
|
Academic Article
|
Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1).
|
Academic Article
|
Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes.
|
Academic Article
|
Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial.
|
Academic Article
|
Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial.
|
Academic Article
|
New Medications for the Treatment of Diabetes.
|
Academic Article
|
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
|
Academic Article
|
The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth.
|
Academic Article
|
Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study.
|
Academic Article
|
The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.
|
Academic Article
|
Standardized Hybrid Closed-Loop System Reporting.
|
Academic Article
|
Closed-loop insulin delivery systems for patients with diabetes.
|
Academic Article
|
Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose Monitoring.
|
Academic Article
|
Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range.
|
Academic Article
|
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2.
|
Academic Article
|
Expression of barrier proteins in the skin lesions and inflammatory cytokines in peripheral blood mononuclear cells of atopic dogs.
|
Academic Article
|
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
|
Academic Article
|
Emerging Landscape of Continuous Glucose Monitoring.
|
Academic Article
|
Safety and Glycemic Outcomes During the MiniMed? Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
|
Academic Article
|
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes.
|
Academic Article
|
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.
|
Academic Article
|
Reduced hypoglycaemia using liver-targeted insulin in individuals with type 1 diabetes.
|
Academic Article
|
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
|
Academic Article
|
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
|
Academic Article
|
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
|
Academic Article
|
International Consensus of Continuous Glucose Monitor Use in Pharmacological Clinical Trials in Diabetes.
|
Academic Article
|
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
|
Academic Article
|
Past, Present, and Future of Continuous Glucose Monitors.
|
Academic Article
|
Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.
|